Novo Nordisk stock falls 2.5 percent ahead of the open
Published on 09/25/2026 at 02:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Novo Nordisk stock closed at DKK 249.00 in Copenhagen on September 24, 2026, down 2.5 percent from the prior session. The shares had fallen 10.4 percent during the week by the close on September 24, 2026.
September 24, 2026 in numbers
Novo Nordisk A/S (ISIN DK0060534915) recorded a third consecutive losing session on September 24, 2026. The decline followed the company strategy presentation in London, which Copenhagen Post reported had disappointed investors.
TheStreet reported that Novo shares in Copenhagen had fallen about 7 percent on September 21, 2026, after the investor day, while the American depositary shares dropped almost 8 percent. The report linked the reaction to management comments about semaglutide loss of exclusivity and competitive pressure in the obesity-drug market.
Next reporting date on November 4, 2026
The next results update is scheduled for November 4, 2026, when Novo Nordisk is due to report results for the first nine months of 2026, according to TheStreet. The report is expected to provide the next formal update on prescription trends and pricing after the September investor presentation.
